Skip to main content

Security report for chemotechnique.se

Chemotechnique MB Diagnostics AB · Healthcare · Sweden

High risk. 6 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

47/100

Risk levelHigh

0–100, higher is better. How it is calculated

Chemotechnique MB Diagnostics AB is a specialized healthcare company based in Sweden, established in 1981, focusing on providing high-quality patch testing products and services for dermatology professionals worldwide. Their website serves as both an e-commerce platform and an informational resource, offering products like IQ Ultra™ and BasIQ Ultra™ patch test kits, detailed instructions, downloadable record forms, and patient education materials. The company maintains a strong market position as a trusted name in patch testing with a clear target audience of physicians and patients interested in contact allergy diagnosis. Technically, the website employs a custom-built infrastructure leveraging legacy JavaScript libraries such as jQuery 1.8.1 and jQuery UI 1.10.3, integrated with Google Tag Manager, Google Analytics, and Google reCAPTCHA for analytics and security. The site is mobile optimized with responsive design elements and basic accessibility features. However, the use of outdated libraries and lack of advanced security headers like CSP indicate areas for modernization and security enhancement. From a security perspective, the site uses HTTPS with good SSL configuration and includes cookie consent mechanisms, but lacks explicit security policies, incident response contacts, and vulnerability disclosure mechanisms. The presence of outdated JavaScript libraries poses potential security risks. No WAF or blocking mechanisms were detected, and no critical vulnerabilities were found in the visible content. Overall, the security posture is moderate but could be improved with updated libraries and enhanced security headers. The overall risk assessment is low to moderate with a well-established business and professional online presence. Strategic recommendations include upgrading legacy JavaScript libraries, implementing CSP headers, publishing security and incident response policies, and enhancing privacy compliance documentation to strengthen trust and security culture.

Scanned

NIS2 and GDPR posture

GDPR outside view
43/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching chemotechnique.se

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
20
Email security
55
DNS health
65
Network security
100
GDPR outside view
43
Average
47

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Chemotechnique MB Diagnostics AB operates in the healthcare sector, specializing in patch testing diagnostics for allergic contact dermatitis. Their competitive advantage lies in their long-standing reputation since 1981 and comprehensive product range including patented patch test kits and haptens. The business model combines B2B sales to physicians and clinics with B2C informational services for patients. Revenue streams likely include product sales via their webshop and partner collaborations. The company targets dermatologists, patch testing physicians, and patients seeking allergy diagnosis. Growth indicators include digital resources like downloadable forms and a quarterly e-magazine, enhancing customer engagement. The partnership with patchtester.com extends their ecosystem, providing industry news and education. Overall, Chemotechnique demonstrates a focused niche market presence with stable operations and a professional digital footprint.

Security posture

The website demonstrates a moderate security maturity level with HTTPS enforced and integration of Google reCAPTCHA to protect forms. However, the use of outdated JavaScript libraries such as jQuery 1.8.1 introduces potential vulnerabilities. The absence of Content Security Policy headers and lack of published security or incident response policies indicate gaps in security governance and transparency. No visible sensitive data exposure or malware was detected. GDPR compliance is partially addressed via cookie consent and privacy policy, but no explicit data protection officer or vulnerability disclosure program is present. Incident response readiness appears limited due to missing contact channels for security issues. Overall, the security posture is functional but requires improvements to align with best practices and regulatory expectations.

Recommendations

  1. Upgrade all outdated JavaScript libraries, especially jQuery, to the latest stable versions to mitigate known vulnerabilities.
  2. Implement Content Security Policy (CSP) headers to reduce risks of cross-site scripting and other injection attacks.
  3. Publish a dedicated security policy and incident response contact information to improve transparency and readiness.
  4. Establish a vulnerability disclosure program, including a security.txt file, to encourage responsible reporting of security issues.
  5. Enhance privacy compliance by expanding GDPR-related documentation and appointing a Data Protection Officer if applicable.

Contact details published on the site

Addresses
Legal name
Chemotechnique MB Diagnostics AB
VAT number
SE556245005501
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Chemotechnique MB Diagnostics AB
Description
Chemotechnique Diagnostics provides high quality patch testing products and services for dermatology professionals, including haptens, chambers, and related accessories. They also offer online resources such as patch test instructions, record forms, and patient information.
Key services
Patch testing products (IQ Ultra™, IQ Ultimate™, BasIQ Ultra™), Patch test haptens, Online patch test instructions and record forms, Partner page with corporate news and marketing resources, Free quarterly e-magazine 'The Patch Tester'
Content quality
good
Branding
consistent

Technology

Stack
jQuery 1.8.1, jQuery UI 1.10.3, Google Tag Manager, Google Analytics, Google reCAPTCHA v2, Colorbox jQuery plugin, MildMenu navigation plugin, Custom JavaScript for UI interactions
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • Use of HTTPS
  • Google reCAPTCHA on forms
  • Cookie consent banner
  • No visible exposed credentials
  • Form validation in JavaScript

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges
  2. Clear business focus on patch testing products and services
  3. Use of multiple Google services for analytics and tag management
  4. Presence of cookie consent banner indicating some privacy compliance
  5. No visible terms of service page found
  6. Use of outdated JavaScript libraries may pose security risks
  7. No explicit security or incident response policies published
Technical notes

Notes

The website is built on a custom platform using legacy JavaScript libraries such as jQuery 1.8.1 and jQuery UI 1.10.3, supplemented by plugins like Colorbox and MildMenu for UI enhancements. Google Tag Manager and Google Analytics are used for tracking and marketing analytics, while Google reCAPTCHA protects forms from automated abuse. The site is responsive and mobile-friendly with basic accessibility features. Performance is moderate, with asynchronous loading of scripts and optimized CSS. However, the use of outdated libraries and lack of modern security headers indicate technical debt and potential risks. No CMS or major frameworks were detected, suggesting a bespoke solution. Opportunities exist to modernize the tech stack, improve security headers, and enhance accessibility and SEO further.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with chemotechnique.se. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review chemotechnique.se.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.